Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Curr Opin Microbiol. 2016 Jun 16;33:35–40. doi: 10.1016/j.mib.2016.05.016

Table 1.

Recent studies on peptides with specific anti-biofilm activity.

Peptide Minimal Inhibitory Concentration Active biofilm concentration Active against Reference
AS10 50 μMa 0.22 μMb C. albicans [16]
KT2 and RT2 5 – 18 μM 1 μMc E. coli [13]
SB056 and derivatives 10 – >40 μM 5–20 μMd S. epidermidis, P. aeruginosa [14]
Cyclic lipopetide 3 22 –55 μM 4 μMc S. aureus, P. aeruginosa [15]
LL-37 and derivatives 32 μg/ml 1–16 μg/mld S. aureus, E. coli [9,31]
(IDR-)1018 8 – 128 μg/ml 2–8 μg/mlb A. baumannii, E. coli, K. pneumoniae, P. aeruginosa, S. enterica, S. aureus [10]
DJK-5 1.6 – 16 μg/ml 0.8 – 4 μg/mlb as for IDR-1018 [11]
DJK-6 4 – 16 μg/ml 0.5 – 8 μg/mlb as for IDR-1018 [11]
a

Minimal fungicidal concentration

b

Minimal biofilm inhibitory concentration

c

Active concentration in flow cells

d

Concentrations showing biofilm inhibition